Trial Profile
Exploring Gilenya in Nab+ MS patients
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 21 Oct 2011
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms ENGYNE
- 21 Oct 2011 New trial record